Deadline: August 13, 2014
Uniting Against Lung Cancer, a nonprofit organization dedicated to providing funding for innovative research, has issued a Request for Proposals for its Legacy Program, the goal of which is to fund lung cancer research that can improve treatment and lead to a cure. In 2013, UALC awarded more than $1.5 million in research grants and expects to increase its support for research in 2014.
The program prioritizes novel ideas with the potential to make a significant impact on current treatment of lung cancer and patient survival, and places a high priority on funding research that demonstrates a clear path to improving patient care. Cross-disciplinary collaborations are strongly encouraged.
Areas of interest include but are not limited to developing novel therapies with the potential to cure lung cancers, genetic subsets of lung cancer/personalized medicine, primary and secondary drug sensitivity/resistance, lung cancer in never-smokers, improving outcomes in early-stage disease, and small-cell lung cancer.
Awards will range up to $100,000, to be paid over two years.
Investigators at all levels are encouraged to apply. While collaborations with industry partners are strongly encouraged, the principal investigator must be an academic researcher.